U.S. Stock News

Wondering if American Express at around US$316 per share is still offering value or if the easy gains are behind it? This breakdown is designed to help you weigh that up with a clear focus on price versus fundamentals. The stock has returned 4.9% over the last 7 days and 3.6% over the last 30 days, while the year-to-date return is a 15.1% decline, compared with a 21.8% return over the last year and 105.8% and 128.0% over the last 3 and 5 years respectively. Recent attention on American...

FDA review extension puts spotlight on Travere Therapeutics The latest move in Travere Therapeutics (TVTX) comes after the FDA extended its review of the supplemental New Drug Application for Filspari. The agency set a new April 2026 action date that reshapes the timeline investors are watching. See our latest analysis for Travere Therapeutics. Travere’s share price has reacted quickly to the FDA update, with a recent 9.5% jump and a 10.65% 1 month share price return. However, the year to...

If you are wondering whether RenaissanceRe Holdings at around US$307 per share still offers value, or if most of the upside is already reflected in the price, this article breaks that question down for you. The stock has recent returns of 3.9% over 7 days, 3.5% over 30 days, 12.8% year to date, 29.3% over 1 year, 51.3% over 3 years and 86.3% over 5 years. These figures naturally raise questions about what is already priced in. Recent news coverage has focused on RenaissanceRe Holdings as a...

Citi’s recent cut to its Polaris (PII) price target, tied to higher macro uncertainty, came just as Q1 North America off road retail units were slightly ahead of management’s earlier expectations. See our latest analysis for Polaris. At a share price of $55.38, Polaris has seen a 5.03% 30 day share price return after a sharp 24.76% share price decline over 90 days. The 1 year total shareholder return of 58.81% contrasts with weak 3 and 5 year total shareholder returns. If this kind of reset...

Wondering if Freshpet at around US$65 per share is priced for opportunity or already reflects its prospects? This article walks through what the current valuation really suggests. The stock recently closed at US$65.03, with a 7 day return of 8.2%, a 30 day return decline of 21.5%, and a 1 year return decline of 21.5%. This makes the recent move particularly important to put in context. Over a longer stretch, Freshpet has a year to date return of 8.1%, a 3 year return of 2.8%, and a 5 year...

If you are wondering whether Visteon at around US$97 per share is still offering value, it helps to look past the headline price and focus on what the current valuation is really telling you. The stock has returned 4.7% over the last 7 days, 5.7% over 30 days, 0.1% year to date and 32.7% over the past year. The 3 year and 5 year returns of 33.7% and 17.9% highlight that the longer term experience has been more mixed. Recent coverage of Visteon has focused on its position in the auto...

In early April 2026, DXC Technology announced a new multi-year agreement with ServiceNow to act as Customer Zero for ServiceNow’s Core Business Suite, deploying agentic AI across its Global Business Services model to modernize complex, multivendor enterprise operations. This move effectively turns DXC into a large-scale proving ground for ServiceNow’s AI platform, generating validated, reusable automation blueprints and industry use cases that can be rolled out to other enterprises. Next,...

Samsara recently reported a fourth-quarter earnings beat and constructive fiscal 2027 outlook, highlighting progress toward 19% operating margins and scalable growth. Management emphasized the role of its large AI-enabled data platform as a key driver of future operational efficiency and safety solutions for customers. We’ll now explore how this stronger margin outlook and AI-enabled platform shape Samsara’s investment narrative for long-term-oriented investors. This technology could replace...

Event Overview and Recent Share Performance Recent trading in Supernus Pharmaceuticals (SUPN) has drawn attention, with the stock closing at US$51.61 and showing mixed short term performance, including a small gain over the past week and a decline over the past month. See our latest analysis for Supernus Pharmaceuticals. Beyond the latest move, the 1 year total shareholder return of 62.5% and 5 year total shareholder return of 61.94% suggest sustained interest in Supernus Pharmaceuticals,...

If you are wondering whether News at around US$24.89 is offering value or just noise, you are not alone. The share price has moved 0.7% over the last 7 days and 1.4% over the last 30 days, while year to date it is down 5.0% and the 1 year return is a 4.2% decline. The 3 year return sits at 47.3% and the 5 year return at a 1.4% decline. Recent headlines around News have focused on the stock's mixed return profile across different time frames and how that contrasts with investors' expectations...

Brookfield Infrastructure Partners (NYSE:BIP) has been in focus after a high profile analyst upgrade, fresh recognition on top dividend stock lists, and attention on its upcoming earnings and ongoing unit buybacks. See our latest analysis for Brookfield Infrastructure Partners. At a latest share price of $36.71, Brookfield Infrastructure Partners has seen a 9.13% 90 day share price return and a 31.46% 1 year total shareholder return, suggesting momentum has been building as investors respond...

Nutanix (NasdaqGS:NTNX) used its .NEXT event over the past week to announce an expansion of its AI and cloud platform, including new Agentic AI capabilities and NKP Metal for bare metal Kubernetes. The company introduced expanded multitenant IaaS features aimed at service providers, with a focus on those migrating from VMware environments. Nutanix rolled out new verified partner offerings and onboarding incentives, alongside deeper integrations with partners such as NetApp and Cisco. The...

In recent weeks, IonQ has combined strong fourth-quarter 2025 results and ongoing quantum technology milestones with new partnerships, government funding from Maryland, and leadership appointments to support its expansion. At the same time, investor sentiment has been pressured by large shareholder resale plans, insider selling activity, and concerns around sector-wide risk appetite amid geopolitical tensions. With analyst reassessments occurring alongside heightened geopolitical...

A short seller report from Culper Research accused ADMA Biologics (ADMA) of channel stuffing and inflating revenue growth, followed by multiple law firms launching securities law investigations and a sharp one day share price drop. See our latest analysis for ADMA Biologics. Against this backdrop of short seller allegations and legal investigations, ADMA Biologics’ recent 1-day share price return of 6.16% and 7-day share price return of 7.90% follow a much weaker 30-day share price return of...

Stock performance snapshot and what stands out Unum Group (UNM) has drawn fresh attention after a recent share move, with the stock up 2.4% over the past day and 5% over the past week, inviting a closer look at recent returns. See our latest analysis for Unum Group. While the recent 1 week share price return of 5% and 1 month share price return of 6.32% point to short term momentum from the current US$77.55 level, the 90 day share price return of a 3.51% decline and the more moderate 1 year...

Wondering if Workday at around US$119 per share is a bargain or a value trap? This article breaks down what that price could really mean for you. The stock has seen a 7.7% decline over the last week, a 19.6% decline over the last month, and is down 42.1% year to date, with a 48.5% decline over the last year and a 54.1% decline over five years. Recent coverage around Workday has focused on how investors are reassessing software names more broadly, and what that might mean for longer term...

Kanzhun (NasdaqGS:BZ) has accelerated its capital return plan after recently repurchasing millions of shares and committing to distribute at least 50% of adjusted net income via buybacks and dividends over the next three years. See our latest analysis for Kanzhun. The 1 day share price return of 2.5% to US$13.49 comes after a year to date share price decline of 35.5% and a 1 year total shareholder return of 11.0% in the red. This suggests that recent buyback news appears to be lifting short...

If you are wondering whether SM Energy at around US$28.81 is priced for opportunity or already reflects its strengths, the starting point is to understand what the market is currently paying relative to the fundamentals. The stock has been volatile in the short term, with a 2.3% decline over the last 7 days, a 10.7% gain over the past month, a 50.6% return year to date, and a 22.4% return over the last year. These moves sit against a longer backdrop where SM Energy has delivered a 4.6%...

Why OGE Energy is back in focus after fresh analyst attention OGE Energy (OGE) is back on investors’ radar after Argus raised its outlook, highlighting steady earnings growth, tight cost control, and a 3.50% dividend yield, along with active financing and regulatory developments. See our latest analysis for OGE Energy. The recent analyst attention comes after a strong run in the shares, with a 90 day share price return of 15.48% and a 1 year total shareholder return of 17.90%. This suggests...

Southwest Airlines (NYSE:LUV) plans to restrict each traveler to one portable charger on all flights. The new policy is scheduled to take effect on April 20, 2026. The airline cites fire safety concerns linked to lithium based power banks as the reason for the change. Southwest Airlines is a major U.S. low cost carrier that relies heavily on high aircraft utilization and quick turnarounds, which makes any safety or cabin policy change relevant to operations. Portable chargers have become...

Wondering if Home Depot at around US$336 still makes sense for your portfolio, or if the market price is getting ahead of the underlying value? The stock is up 2.0% over the last 7 days, but shows a 4.9% decline over 30 days, a 2.8% decline year to date, and a 3.0% decline over 1 year, while the 3 year and 5 year returns sit at 24.8% and 18.7% respectively. Recent headlines have focused on Home Depot's role as a bellwether for US housing and renovation demand, as well as commentary on...

Wondering whether Genco Shipping & Trading's current share price reflects its true worth, or if the market is missing something? The stock last closed at US$24.32, with returns of 4.7% over 7 days, 12.7% over 30 days, 31.9% year to date and 104.9% over the past year. This raises questions about how much of the story is already in the price. Recent coverage has focused on Genco Shipping & Trading's position within the shipping sector and how investors are reacting to changing sentiment around...

Columbia Banking System (COLB) drew attention after President Trump announced a two week suspension of attacks on Iran. This move coincided with lower crude prices and a friendlier backdrop for bank stocks. See our latest analysis for Columbia Banking System. At a share price of US$28.88, Columbia Banking System has seen a 1-month share price return of 6.53% and a 1-year total shareholder return of 37.23%. However, the 90-day share price return shows a decline of 1.63%, which suggests some...

Wondering whether OSI Systems at around US$288 a share still represents value, or if most of the opportunity is already priced in? This article walks through the key signals to help you frame that question for yourself. The stock has recent returns of 9.4% over 7 days, 2.2% over 30 days, 12.9% year to date, 50.9% over 1 year, 180.6% over 3 years and 198.6% over 5 years, which naturally raises questions about where valuation stands today. Recent coverage has kept attention on OSI Systems,...